London, UK & New Haven, USA. January 24th 2017: Digital Science, a leading technology company serving the needs of scientific and research communities has made an investment in IFI CLAIMS Patent Services, a leading supplier of patent data for resellers and innovators based in New Haven, Connecticut, USA. The investment bolsters Digital Science's portfolio of technology tools and services to support the research and healthcare sectors.
IFI CLAIMS provides continually updated global patent data to leading patent application providers and corporate researchers worldwide. Comprised of more than 100 million records from 90 countries, including 53 million full text records from 18 jurisdictions, the IFI CLAIMS patent database is accessible through the industry-leading CLAIMS Direct API.
Application developers use CLAIMS Direct to quickly prototype and deploy operational patent search and analysis solutions. Researchers use CLAIMS Direct to deploy private patent databases in the cloud, or inside the corporate firewall.
Digital Science targets businesses which complement its ecosystem of services in the research and scientific services space and funds and develops online products and services to empower researchers to be more efficient; pushing research to be more reproducible and of higher quality. Its portfolio companies include a host of leading and admired brands including Altmetric, BioRAFT, Figshare, Labguru, Overleaf, ReadCube, GRID, TetraScience, Transcriptic, Symplectic and ÜberResearch. It is operated by global media company, Holtzbrinck Publishing Group.
Commenting on the investment, Michael Hock, Managing Director of Holtzbrinck Digital said today, "As research institutions focus on increasing their tech and knowledge transfer for commercial and competitive advantage, patent data offer a useful lens through which to view the impact of academia and research on the economy. This makes the addition of IFI CLAIMS to our investment portfolio a perfect fit for us.
"In addition to sharing very similar goals, there is also significant potential for co-operation and integration with other products in our portfolio of companies, including Altmetric, ÜberResearch, Labguru, BioRAFT and Figshare."
Mike Baycroft, CEO of IFI CLAIMS Patent Services and Fairview Research said today, "We are very pleased to be working with the team at Digital Science. This investment will allow IFI CLAIMS to expand its data coverage and develop new services for our clients. IFI adds a new dimension to the Digital Science portfolio and we are looking forward to a bright future together".
ends.
Notes to Editors:
About IFI CLAIMS Patent Services
IFI CLAIMS Patent Services is the preeminent producer of value-added patent databases and the innovative CLAIMS DIRECT API. Application developers can use CLAIMS Direct to quickly prototype and deploy operational patent search and analysis solutions. Researchers can use CLAIMS Direct to deploy private patent databases in the cloud, or inside the corporate firewall. Based in the U.S. in New Haven, Conn., with satellite offices in Munich, Germany, and Barcelona, Spain, IFI CLAIMS is a division of Fairview Research, a provider of data-enrichment technology and services for information retrieval and analysis. IFI CLAIMS publishes the annual Top U.S. Patent Recipients, the world's most trusted ranking of patent assignees. More information, visit IFI CLAIMS online at www.ificlaims.com and follow @ificlaims on Twitter.
About Digital Science
Digital Science is a technology company serving the needs of scientific and research communities, at the laboratory bench or in a research setting. It invests in and incubates scientific software companies that simplify the research cycle, making more time for discovery. Its portfolio companies and investments include a host of leading and admired brands including: Altmetric, BioRAFT, Figshare, Overleaf, Peerwith, ReadCube, TetraScience, Transcriptic, Symplectic and ÜberResearch. It is operated by global media company, Holtzbrinck Publishing Group.
For more information, visit www.digital-science.com and follow @digitalsci on Twitter.
About Holtzbrinck Publishing Group
Holtzbrinck Publishing Group is an international media company active in science and education, consumer book publishing, trade publishing, newspaper and magazines, as well as electronic media and services. Holtzbrinck Digital Information & Services combines the internet holdings of the Holtzbrinck Publishing Group. The company acts as a strategic management holding that actively leads its portfolio of companies made up of high-growth and market-leading online businesses, and helps them to develop.
For more information, please visit: www.holtzbrinck-digital.com
Media enquiries:
For Digital Science
Lisa Hulme / Anna Cahill James
[email protected] t: +44 (0)7941 232333
[email protected] t: +1 415 866 3663
For IFI CLAIMS
Catherine Suski, IFI CLAIMS
[email protected]


U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 



